Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation
- PMID: 7820141
- DOI: 10.1007/BF00185673
Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation
Abstract
Secondary resection of metastases remaining after inductive chemotherapy of advanced germ-cell tumors has thus far been obligatory. The absence of malignant components in one-third of all residual tumors and the high risk of the operation have led several authors to reconsider the criteria for this approach. In a retrospective study of 153 cases (127 evaluable) we investigated the histology of the primary tumor and the size of the residual tumor with regard to residual histology and outcome. Patients were divided into the following three groups according to the histology of the primary tumor: group I, pure seminoma (16 patients); group II, nonseminoma without teratoma (32 patients); and group III, nonseminoma with teratoma (79 patients). Among the 16 purely seminomatous tumors, the residual masses ranged from 2 to 12 cm; 12 consisted of necrotic tissue only, 3 contained malignant germ-cell elements, and 1 contained adult teratoma. The residuals of primarily teratoma-free nonseminomas measured 2-16 cm; the smallest residual tumor containing active malignant elements measured 4 cm, and the diameter of the largest necrotic residue was 6 cm. Four residuals contained mature teratoma. The size of residuals from teratomatous primary tumors was 3-24 cm; the smallest malignant tumor measured 5 cm, and the diameter of the largest purely necrotic mass was 8 cm. According to our results, a secondary operation may be omitted if the residual mass of a primary seminoma is smaller than 5 cm or if that of a primary nonseminoma without teratoma is less than 3 cm in diameter.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.Cancer. 1994 Aug 15;74(4):1329-34. doi: 10.1002/1097-0142(19940815)74:4<1329::aid-cncr2820740424>3.0.co;2-l. Cancer. 1994. PMID: 8055456
-
Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses.Cancer. 2002 Mar 15;94(6):1668-76. doi: 10.1002/cncr.10440. Cancer. 2002. PMID: 11920527
-
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.Cancer. 1996 Aug 1;78(3):480-6. doi: 10.1002/(SICI)1097-0142(19960801)78:3<480::AID-CNCR15>3.0.CO;2-V. Cancer. 1996. PMID: 8697394
-
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.J Urol. 1997 Aug;158(2):474-8. doi: 10.1016/s0022-5347(01)64506-3. J Urol. 1997. PMID: 9224327 Review.
-
Postchemotherapy residual masses in advanced seminoma: current management and outcomes.Expert Rev Anticancer Ther. 2005 Oct;5(5):869-74. doi: 10.1586/14737140.5.5.869. Expert Rev Anticancer Ther. 2005. PMID: 16221056 Review.
Cited by
-
Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours.Br J Cancer. 2000 Nov;83(10):1274-80. doi: 10.1054/bjoc.2000.1416. Br J Cancer. 2000. PMID: 11044349 Free PMC article.
-
[Regression of germ cell tumors after chemotherapy].Pathologe. 2004 Nov;25(6):469-73. doi: 10.1007/s00292-004-0721-6. Pathologe. 2004. PMID: 15549315 German.
-
Imaging of abdominal nodal spread in malignant disease.Eur Radiol. 1996;6(3):262-74. doi: 10.1007/BF00180591. Eur Radiol. 1996. PMID: 8797995 Review.
References
MeSH terms
LinkOut - more resources
Medical